Use Cytopenias in a sentence

1. Cytopenias are a common occurrence following CAR T-cell infusion. Grades 3–4 anemias, thrombocytopenia, leukopenia, neutropenia, and lymphopenia are frequently reported

Cytopenias, Common, Car, Cell

2. There is often difficulty in determining the etiology of Cytopenias occurring after CAR T-cell infusions.

Cytopenias, Car, Cell

3. Cytopenias associated with alemtuzumab are often transient, although erythrocyte and platelet transfusions may be required (181 R)

Cytopenias

4. Grade 3–4 Cytopenias have been observed in patients with mycosis fungoides receiving intravenous alemtuzumab 30 …

Cytopenias

5. There are various immune Cytopenias associated with systemic lupus erythematosus (SLE)

Cytopenias

6. Studies characterizing the CVID phenotype associated with autoimmune Cytopenias have mostly been limited to large referral centers.

Characterizing, Cvid, Cytopenias, Centers

7. This topic review discusses an approach to evaluating and managing Cytopenias (anemia, thrombocytopenia, neutropenia, pancytopenia) in people with HIV

Cytopenias

8. As with the anemias, the other Cytopenias can be thought about in two broad categories to explain their causes: 1) decreased cellular production, or 2) increased cellular destruction.

Cytopenias, Can, Categories, Causes, Cellular

9. There is great variation in Cytopenias in cirrhotic patients with same severity and hypersplenism and their causative factors are not clear

Cytopenias, Cirrhotic, Causative, Clear

10. Cytopenias: Obtain complete blood counts (CBC) and platelet counts at weekly intervals during therapy and CD4 counts after therapy until recovery to ≥200 cells/µL

Cytopenias, Complete, Counts, Cbc, Cells

11. KEYWORDS: autoimmune Cytopenias, WAIHA, CAD, ITP, AIN INTRODUCTION Failure to maintain self-tolerance is the dominant pathophys-iologic mechanism binding the autoimmune Cytopenias, a group of disorders characterized by the immune mediated destruction of …

Cytopenias, Cad, Characterized

12. Treatment with the thrombopoietin receptor agonist eltrombopag significantly improved Cytopenias and was well-tolerated in patients with low to intermediate-2 risk myelodysplastic syndromes.

Cytopenias

13. Patients with unexplained Cytopenias may never receive a definitive diagnosis, or may eventually be classified as having myelodysplastic syndromes (MDS, a myeloproliferative neoplasm [MPN] or, if their Cytopenias persist, as having idiopathic cytopenia of undetermined significance [ICUS]).

Cytopenias, Classified, Cytopenia

14. Cytopenias with associated "dysplasia" can be the result of medications (especially chemotherapeutic agents)

Cytopenias, Can, Chemotherapeutic

15. Aplastic anemia also presents with Cytopenias and can raise concern for a hypoplastic MDS, but acquired aplastic anemia typically lacks significant morphologic dysplasia and has a normal karyotype.

Cytopenias, Can, Concern

16. Autoimmune Cytopenias are observed in 5% to 10% of patients with CLL, and may precede, occur at time of diagnosis or develop as a complication of therapy

Cytopenias, Cll, Complication

17. Peripheral blood Cytopenias are common in SLE and their management can be challenging

Cytopenias, Common, Can, Challenging

18. Cytopenias after day 28 in allogeneic hematopoietic cell transplantation: impact of recipient/donor factors, transplant conditions and myelotoxic drugs

Cytopenias, Cell, Conditions

19. Hematologists learn early in training how to evaluate patients with Cytopenias, and this remains a core task of hematology clinical practice

Cytopenias, Core, Clinical

20. But when common cytopenia-inducing causes (eg, vitamin or essential mineral deficiency, infection, immune dysregulation, drug effect, bleeding, organ dysfunction, neoplasia) have been systematically excluded, yet Cytopenias persist, clinicians may be

Common, Cytopenia, Causes, Cytopenias, Clinicians

21. Cytopenias may herald or concur with the onset of various systemic rheumatic diseases

Cytopenias, Concur

22. Autoimmune Cytopenias may be associated with infections, systemic autoimmune diseases, neoplasias, drug toxicity, and other factors

Cytopenias

23. The autoimmune Cytopenias are a group of disorders resulting primarily from autoantibody-mediated destruction of blood cells, with variable clinical sequelae depending on the severity and lineage affected

Cytopenias, Cells, Clinical

24. Cytopenias are the most common HIV-associated hematological abnormality

Cytopenias, Common

25. Cytopenias have been associated with several factors including sex, race/ethnicity, geographical location and comorbidities such as tuberculosis, hepatitis B infection, fever and oral candidiasis

Cytopenias, Comorbidities, Candidiasis

26. Cytopenias become more prevalent as HIV progresses and are often fatal

Cytopenias

27. •Cytopenias: Obtain complete blood counts (CBC) and platelet counts at weekly intervals during therapy and CD4 counts after therapy until recovery to ≥200 cells/µL

Cytopenias, Complete, Counts, Cbc, Cells

28. Chemotherapy-induced myelosuppression (along with other Cytopenias) Hematopoietic cell mutation involving GATA2

Chemotherapy, Cytopenias, Cell

29. Cytopenias are a common feature, but up to 30% of patients can present with cytosis

Cytopenias, Common, Can, Cytosis

30. When Cytopenias remain unexplained despite an appropriate evaluation, they may be described as one of the following : Idiopathic cytopenia of undetermined significance (ICUS) Clonal cytopenia of undetermined significance (CCUS) This topic will discuss the diagnosis and management of unexplained Cytopenias in adults.

Cytopenias, Cytopenia, Clonal, Ccus

31. This article summarizes immune Cytopenias seen in patients with SLE, and it also discusses management of these Cytopenias

Cytopenias

32. AB - There are various immune Cytopenias associated with systemic lupus erythematosus (SLE)

Cytopenias

33. Bone marrow involvement causes suppression of normal hematopoiesis and consequent peripheral Cytopenias, in our study there was a statistically significant difference in frequency of leucopenia and thrombocytopenia in cases with and without marrow infiltration (table 1) pancytopenia was found in 7 cases (16.6%) with marrow infiltrates in

Causes, Consequent, Cytopenias, Cases

34. Cytopenias are a common end result of this immune dysregulation, and neurologic manifestations can be seen in approximately one-third of those affected with this disorder

Cytopenias, Common, Can

35. 8 – 10 To diagnose diseases such as HLH, the patient must meet at least 5 of the following laboratory and/or clinical criteria: fever, Cytopenias (hemoglobin <9 g/dL

Clinical, Criteria, Cytopenias